The PROMOGRANTM Family Challenge

Are your patients’ wounds in the early development of chronicity?

Does your patient have complexities and comorbidities that could result in the wound not healing properly?

Then why not give your patients the best chance, try using PROMOGRANTM Family dressings today!

Why wait?

Clinically shown to increase rates of healing of chronic wounds if used earlier in the treatment regime.1

Start using now and give your patients the best chance.

Contact us here to get started
References:
1. Cullen B, Gibson M, Nisbet L. Early adoption of collagen/ORC therapies improves clinical outcomes. Poster presented at: World Union of Wound Healing Societies (WUWHS); 2012; Japan.

So what are PROMOGRAN™ Matrix and PROMOGRAN PRISMA™ Matrix?

Clinically proven for over 18 years PROMOGRANTM is a COLLAGEN + ORC Dressing designed to provide the optimum healing environment by reducing MMPs and elastase:
  • Faster Healing
  • 4 times more likely to heal
  • Protection from infection
  • Proven to reduce costs
  • Improves patients lives
The Right Balance of Materials —
Designed to make a powerful difference:

Clinically proven for over 18 years, PROMOGRAN™ MATRIX AND PROMOGRAN PRISMA™ MATRIX are designed to provide the optimum healing environment:

  • Early treatment increased healing1
  • 8.5 times more likely to heal2
  • Protection from infection3
  • Proven to reduce costs4
Download brochure
References: 1. Cullen B, Gibson M, Nisbet L. Early adoption of collagen/ORC therapies improves clinical outcomes. Poster presented at: World Union of Wound Healing Societies (WUWHS); 2012; Japan.
2. Lazaro-Martinez JL, Garcia-Morales E, Beneit-Montesinos JV, Martinez-de-Jesus F, Aragon-Sanchez FJ. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers. Cir Esp. 2007;82(1):27–31.
3. Gottrup F, Cullen B, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson M. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Repair Regen. 2013;21(2):216–225.
4. Guest JF, Rana K, Singh H, Vowden P. Cost-effectiveness of using a collagen-containing dressing plus compression therapy in non-healing venous leg ulcers. J Wound Care. 2018;27(2):68-78. doi:10.12968/jowc.2018.27.2.68
5. Nisi G, Brandi C, Grimaldi L, Calabro M, D’Aniello C. Use of a protease-modulating matrix in the treatment of pressure sores. Chir Ital. 2005;57(4):465–8
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product Instructions for Use prior to application.

© 2021 3M. All rights reserved. 3M and the other marks shown are marks and/or registered marks. Unauthorized use prohibited. PRA-PM-EI-00435 (01/21). The information included in this website has been prepared for and is intended for viewing by a EMEA audience. This website contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions. The information on this website is intended for healthcare professionals. Patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site, including the risks and benefits of certain products and services that may be discussed on this site.